News

Latest news and announcements:

12/31/2017

  • Official launch of Zhuhai Macan Dynamic Biotechnologies Ltd. in Hengqin New Area in Zhuhai, China in 2017 Q4

    In the fourth quarter of 2017, we have officially launched a new company, Zhuhai Macan Dynamic Biotechnologies Ltd., in Hengqin New Area in Zhuhai, China. This is surely an important milestone for us to develop our business in mainland China. The new company has also become one of the incubation technology companies in the Guangdong and Macao Traditional Chinese Medicine Science and Technology Industrial Park.

    In an endeavor to ensure the quality of Chinese medicine, Macan Dynamic Biotechnologies Ltd focuses on the research and development of the use of microfluidic chips. For instance, we hope to develop microfluidic chips that can be used for high-speed identification and authentication of Chinese ginseng and American ginseng, and other Chinese medicinal herbs.

    In addition, we will study the effect of Chinese medicine as inhibitors to address the multi-drug resistance of cancerous cells in cancer patients with the use of the Single Cell Analyzer (SCB). Patients and medical practitioners can make reference from the study results to formulate personalized cancer treatment protocol with high accuracy.

12/5/2017
  • Commencement of preliminary study on multi-drug resistance of lung cancer clinical samples

    Our company has engaged the Macau Institute for Applied Research in Medicine and Health of the Macau University of Science and Technology on a preliminary study on multi-drug resistance of lung cancer clinical samples using Single Cell Bioanalyzer. After completion of this project we have a plan to carry out further clinical study using more clinical samples.

    The outcome from this preliminary study of multi-drug resistance of lung cancer clinical samples will give a guideline on personalized treatment using drugs on lung cancer patients. This will enhance the efficacy of treating the lung cancer disease.

    There will also be participation from certain Macau medical institutions in our project. In this way we hope to make contribution to the biotechnology sector in Macau.

20/10/2016

  • Our company participated in the 2016 Macao International Trade & Investment Fair
 
Our booth in the Fair
 
Visitors from Macau University of Science and Technology

23/6/2016

  • Technology transfer and training in SFU Canada - Through our liaison, Dr. Xing Xing Fan of MUST was sent to Simon Fraser University in Canada for technology transfer and training on the use of Single Cell Bioanalyzer from June 23 to July 1, 2016. He has also given a presentation on “Targeting non-small cell lung cancer by regulating lipid metabolism” on June 27, 2016 in SFU.
 
Dr. Fan giving presentation in SFU
 
Dr. Fan giving presentation in SFU

28/4/2016

  • First unit of Single Cell Bioanalyzer arrived in Macau - The first unit of Single Cell Bioanalyzer has arrived in Macau University of Science and Technology in mid April 2016.  Installation and training were carried out on April 28 and 29.

 
Training by Zellchip on use of Single Cell Bioanalyzer in MUST
 
Training by Zellchip on use of Single Cell Bioanalyzer in MUST

20/7/2015


  • Through our contacts and participation, Macau University of Science and Technology in collaboration with Simon Fraser University in Canada, carried research using SCB to study how gefitinib increased uptake of chemotherapy drugs in cancer cells. The research paper was presented in  meeting of IBCELC held in Hokkaido, Japan, on July 20, 2015.


18/12/2014

  • Our company in December 18, 2014 signed a memorandum of cooperation in scientific research of traditional Chinese medicine with Macau University of Science and Technology.
  • Through our contacts and participation, Macau University of Science and Technology in collaboration with Simon Fraser University in Canada, performed test on the ROS produced by lung cancer cells using SCB.